- Home
- MDXG vs CHY Comparison
MDXG vs CHY Comparison
Compare MDXG & CHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- CHY
- Stock Information
- Founded
- MDXG 2006
- CHY 2003
- Country
- MDXG United States
- CHY United States
- Employees
- MDXG N/A
- CHY N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- CHY Investment Managers
- Sector
- MDXG Health Care
- CHY Finance
- Exchange
- MDXG Nasdaq
- CHY Nasdaq
- Market Cap
- MDXG 877.4M
- CHY 839.8M
- IPO Year
- MDXG N/A
- CHY N/A
- Fundamental
- Price
- MDXG $6.33
- CHY $10.83
- Analyst Decision
- MDXG Strong Buy
- CHY
- Analyst Count
- MDXG 2
- CHY 0
- Target Price
- MDXG $11.50
- CHY N/A
- AVG Volume (30 Days)
- MDXG 842.0K
- CHY 128.3K
- Earning Date
- MDXG 07-30-2025
- CHY 01-01-0001
- Dividend Yield
- MDXG N/A
- CHY 10.11%
- EPS Growth
- MDXG N/A
- CHY N/A
- EPS
- MDXG 0.27
- CHY N/A
- Revenue
- MDXG $352,375,000.00
- CHY N/A
- Revenue This Year
- MDXG $9.55
- CHY N/A
- Revenue Next Year
- MDXG $11.43
- CHY N/A
- P/E Ratio
- MDXG $23.26
- CHY N/A
- Revenue Growth
- MDXG 5.34
- CHY N/A
- 52 Week Low
- MDXG $5.47
- CHY $9.97
- 52 Week High
- MDXG $10.14
- CHY $12.16
- Technical
- Relative Strength Index (RSI)
- MDXG 47.21
- CHY 52.62
- Support Level
- MDXG $6.57
- CHY $10.78
- Resistance Level
- MDXG $6.85
- CHY $11.11
- Average True Range (ATR)
- MDXG 0.29
- CHY 0.10
- MACD
- MDXG 0.07
- CHY -0.02
- Stochastic Oscillator
- MDXG 39.50
- CHY 34.88
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About CHY Calamos Convertible and High Income Fund
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.